Herpes Simplex Keratitis
📧 Sign up to get email alerts when something new happens for Herpes Simplex Keratitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2026-01-20FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for ZIRGAN (ganciclovir ophthalmic gel) from Bausch & Lomb Incorporated, resulting in labeling c…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization. [Phase 1, Phase 2]
A Phase 1/2 clinical study is evaluating intrastromal anti-VEGF injections to treat corneal neovascularization in patients with herpes simpl…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis [Phase 2]
A Phase 2a clinical trial is evaluating the safety, tolerability, and efficacy of BD111 for herpes simplex keratitis caused by HSV-1; the st…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis [Phase 4]
Phase 4 clinical trial evaluating outcomes of cyclosporine eye drops for managing herpetic keratitis has completed.
-
CLINICAL_TRIALS research · 2017-01-09Clinical Trial Update: Observation on the Herpes Simplex Keratitis
This update describes an ongoing clinical trial observing herpes simplex keratitis, with the current status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis [Phase 4]
Phase 4 clinical trial comparing flocked swabs to traditional fiber swabs for diagnosing herpes simplex epithelial keratitis has been termin…
-
FDA approval · 2014-04-29FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)
The FDA has approved a supplemental application for Zirgan (ganciclovir ophthalmic gel) submitted by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)
This completed trial evaluated the efficacy of two diagnostic assays for detecting Herpes Simplex Keratitis.
-
CLINICAL_TRIALS research · 2009-09-17Clinical Trial Update: Herpetic Eye Disease Study (HEDS) I [Phase 3]
A Phase 3 clinical trial update for the Herpetic Eye Disease Study I (HEDS I) involving keratitis and ocular herpes simplex; current status …